FXN and hyperinsulinemic hypoglycemia, familial, 4: Our lipidomic profiling showed that two important products of HMG-CoA, CoQ10 and cholesterol, are not affected by frataxin deficiency, which may explain why improvements by idebenone (an analogue of CoQ10) were not statistically significant in clinical trials (56).